PL414926A1 - Medical application of N-substituted 3-amino-4-phenyl-5-oxopyrazolino-carboxamide derivatives for the production of a medicine
- Google Patents
Medical application of N-substituted 3-amino-4-phenyl-5-oxopyrazolino-carboxamide derivatives for the production of a medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Medyczny W Lublinie, Unilab, Lp.filedCriticalUniwersytet Medyczny W Lublinie
Priority to PL414926ApriorityCriticalpatent/PL230472B1/en
Publication of PL414926A1publicationCriticalpatent/PL414926A1/en
Publication of PL230472B1publicationCriticalpatent/PL230472B1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Przedmiotem zgłoszenia jest związek o wzorze ogólnym I oraz nowe zastosowanie medyczne N-podstawionego-3-amino-4-fenylo-5-okso-pirazolinokarboksamidu związku o wzorze I, w którym R oznacza cykloheksyl, 1-naftyl, n-butyl. Związek o wzorze I stosuje się do wytwarzania leku do profilaktyki i leczenia gruźlicy.The subject of the application is a compound of the general formula I and a new medical use of the N-substituted-3-amino-4-phenyl-5-oxo-pyrazolinecarboxamide compound of the formula I in which R is cyclohexyl, 1-naphthyl, n-butyl. The compound of formula I is used in the manufacture of a medicament for the prevention and treatment of tuberculosis.
PL414926A2015-11-242015-11-24Medical application of N-substituted 3-amino-4-phenyl-5-oxopyrazolino-carboxamide derivatives for the production of a medicine
PL230472B1
(en)
3-dodecylsulfanyl-butyric acid to be used as a medicine, preferably to prevent development of insulin immunity and the composition containing 3-dodecylsulfanyl-butyric acid as active substance